At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Opioid kappa receptor agonists; Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Opioid-related disorders; Pain
Most Recent Events
- 16 Jun 2000 Preclinical development for Opioid abuse in USA (Unknown route)
- 16 Jun 2000 Preclinical development for Pain in USA (Unknown route)